Northwestern Medical Faculty Foundation

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)1 trial
• Liver cirrhosis1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Parkinson disease1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 22 trials
• Phase 11 trial
• Phase 1/21 trial
• Phase 31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Pfizer2 trials
• BioNTech SE1 trial
• Madrigal Pharmaceuticals, Inc.1 trial
• Neurocrine Biosciences1 trial

Running trials

• Active, not recruiting

  A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

  NCT03900429· Phase 3· Madrigal Pharmaceuticals, Inc.· Source

Closed trials

• Terminated

  Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

  NCT04101357· Phase 1/2· BioNTech SE· Source

• Completed

  VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

  NCT03562494· Phase 1· Neurocrine Biosciences· Source

• Completed

  Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

  NCT02007512· Phase 2· Pfizer· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

  NCT01889238· Phase 2· Pfizer· Source